New clinical practice guidelines published in Epilepsy Currents recommend updated surgical strategies for patients with drug-resistant epilepsy (DRE). The joint guidelines from the American Epilepsy Society and the Congress of Neurological Surgeons advocate for specialized surgical interventions, such as laser interstitial thermal therapy, over traditional medical management for specific epilepsy syndromes.
For people living with epilepsy, finding a treatment that effectively stops seizures can be a decades-long struggle. When standard anti-seizure medications fail—a condition known as drug-resistant epilepsy—the biological “circuitry” of the brain requires physical intervention. The release of updated clinical guidelines provides evidence-based approaches for evaluating and managing epilepsy surgery candidates, including recommendations for resective or ablative surgery.
- Precision over Resection: For certain types of epilepsy, such as hypothalamic hamartomas, laser-based heat therapy is now strongly recommended over traditional brain tissue removal.
- The Importance of Specialized Care: The guidelines emphasize that every patient with drug-resistant epilepsy should have access to a tertiary epilepsy center for surgical evaluation.
- Shared Decision-Making: Because surgical options like temporal lobectomy carry different risks for memory versus seizure control, patients must participate actively in choosing their specific procedure.
Surgical Strategies for Mesial Temporal Lobe Epilepsy
The new guidelines provide a tiered approach to treatment based on the patient’s risk profile for cognitive decline.
For patients at low risk for cognitive impairment, the panel issued a strong recommendation for anterior temporal lobectomy. In two randomized controlled trials, this surgical resection significantly increased the likelihood of remaining free from disabling seizures at the one- and two-year marks, showing a relative risk of 7.67 compared to medical therapy. However, clinicians must weigh this against “very low-certainty evidence” suggesting potential declines in verbal memory.
For those at higher risk of memory loss, the panel conditionally recommended selective amygdalohippocampectomy or laser interstitial thermal therapy (LITT). While LITT is less invasive, comparative studies show similar seizure outcomes to traditional resection. In one study, LITT reported better verbal memory outcomes, offering a potential lifeline for patients prioritizing cognitive preservation. In a retrospective study of selective amygdalohippocampectomy, 82% of patients achieved seizure freedom, though 73% experienced significant verbal memory declines.
Comparative Outcomes of Epilepsy Surgical Interventions
The following table summarizes the seizure freedom rates and clinical considerations for the primary surgical interventions discussed in the updated guidelines.
| Procedure Type | Target Condition | Seizure Freedom Rate (Approx.) | Primary Clinical Consideration |
|---|---|---|---|
| Anterior Temporal Lobectomy | Mesial Temporal Lobe Epilepsy | High (Significant vs. Medical) | Risk of verbal memory decline |
| Laser Interstitial Thermal Therapy (LITT) | Mesial Temporal Lobe Epilepsy | ~51.85% (at 1 year) | Better verbal memory preservation |
| Callosotomy | Drop Attacks / Encephalopathies | ~22.4% (at 2 years) | Higher risk of serious adverse events |
| LITT (for Hamartomas) | Hypothalamic Hamartomas | ~71.79% (at 2 years) | Strongly recommended over resection |
Resective Surgery Offers High Seizure Freedom Rates for Neocortical Epilepsy
The guidelines also address neocortical epilepsy. For patients aged two and older, the panel conditionally recommended resective or ablative surgery over continued medical therapy. Data from observational studies involving 446 participants—the majority of whom were children—showed a 57.17% seizure freedom rate at one year following resective surgery. In adults, this rate was reported at 65.4%, with permanent neurologic deficits being uncommon.
A critical distinction was made for drug-resistant drop attacks, Lennox-Gastaut syndrome, and other developmental and epileptic encephalopathies. In these complex cases, the panel conditionally recommended callosotomy over vagus nerve stimulation (VNS). While callosotomy showed a 22.4% seizure freedom rate at two years compared to 8.3% for VNS, it carries a higher risk of serious adverse events (21.4% vs. 10.0%). The panel noted that VNS remains an acceptable, often safer alternative for caregivers prioritizing minimized procedural risk.
Laser Precision for Hypothalamic Hamartomas
Hypothalamic hamartomas are addressed in the updated guidelines. In a significant move, the panel strongly recommended laser interstitial thermal therapy (LITT) over traditional surgical resection for these patients. Despite the evidence being categorized as “very low-certainty,” the panel issued a strong recommendation.
Across five noncomparative studies, pediatric patients undergoing LITT achieved a seizure freedom rate of 71.79% at two years. In contrast, when LITT is unavailable, the panel suggests radiosurgery or resection. However, data indicates that for pediatric patients, radiosurgery resulted in a 0% seizure freedom rate at 2.28 years in one comparative study, whereas surgery yielded 40%.
Some authors declared affiliations with biotech, pharmaceutical, and medical device companies.
Surgical Intervention Excludes Patients Younger than 12 Years
Surgical intervention is not appropriate for all epilepsy patients. Patients younger than 12 years are not covered by the specific mesial temporal lobe recommendations in this update.
The evolution of these guidelines suggests that the future of epilepsy care lies in closing the access gap to tertiary centers and moving beyond incremental technical changes toward high-quality, comparative evidence that prioritizes patient-centered outcomes.
